Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Cancer Research|December 16, 2000
Activity of a novel camptothecin analogue, homocamptothecin, in camptothecin-resistant cell lines with topoisomerase I alterationsY Urasaki, Y Takebayashi, Y Pommier
The Journal of Antibiotics|August 1, 1996
YM-24074, a new peptide antibiotic. II. Structural elucidationT Sato, Y Takebayashi, T Tokunaga, et al.
Biochemical and Biophysical Research Communications|February 13, 2001
Nek2 expression and localization in porcine oocyte during maturationT Fujioka, Y Takebayashi, M Ito, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
The novel natural product YM-26567-1 [(+)-trans-4-(3-dodecanoyl-2,4,6- trihydroxyphenyl)-7-hydroxy-2-(4-hydroxyphenyl)chroman]: a competitive inhibitor of group II phospholipase A2A Miyake, H Yamamoto, Y Takebayashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 1999
Poisoning of human DNA topoisomerase I by ecteinascidin 743, an anticancer drug that selectively alkylates DNA in the minor grooveY Takebayashi, P Pourquier, A Yoshida, et al.
Cancer|July 15, 1996
Angiogenesis as an unfavorable prognostic factor in human colorectal carcinomaY Takebayashi, S Aklyama, K Yamada, et al.
Cancer Letters|April 11, 2001
Clinicopathological and prognostic significance of thymidine phosphorylase and proliferating cell nuclear antigen in gastric carcinomaS Konno, Y Takebayashi, M Aiba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
Ecteinascidin 743 induces protein-linked DNA breaks in human colon carcinoma HCT116 cells and is cytotoxic independently of topoisomerase I expressionY Takebayashi, F Goldwasser, Y Urasaki, et al.
Oncology Reports|October 18, 2001
Expression and cisplatin sensitivity of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell linesK Nakayama, K Miyazaki, A Kanzaki, et al.
Cancer Research|February 24, 2001
Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding siteY Urasaki, G Laco, Y Takebayashi, et al.
Pageof 6